Pay in 4 interest-free payments of $6.45 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
10.2337/db10-1707 80
doi:10.1016/j.jcjd.2018.05.008
This process may explain why some patients respond to methylcobalamin but NOT cyanocobalamin
Primary outcome The primary outcome, major adverse cardiovascular events (MACE), was reported in all 11 included studies, comprising of 91,490 participants with 4386 MACE events in the intervention group and 4884 MACE events in the placebo group
US$ 24.85
US$ 23.55
US$ 25.60
US$ 27.32
